UNSPSC 51141582: Tiagabine

This classification denotes an anticonvulsant agent with the molecular formula C20H25NO2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z80I64HMNP, chemically known as 3-piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (r)- but generally known as tiagabine, which bears US NIH Compound Identifier 60648. European Medicines Agency schedules Tiagabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11000MIG.

UNSPSC 51141582 Tiagabine (Commodity) is a pharmaceutical-supply code that appears in state and local procurement records with minimal current activity. The one recent opportunity in the record—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—is actually for naloxone and drug deactivation systems, not tiagabine. The mismatch between the code's nominal scope (a specific anticonvulsant medication) and the actual solicitation content suggests that either the opportunity was miscoded or this code does not currently reflect active state and local purchasing for tiagabine itself.

Seminole County's solicitation, due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract was to run for two years with an optional one-year renewal on a fixed-fee basis, with vendors responsible for all shipping and delivery costs, E-Verify compliance, and applicable insurance coverages. The procurement did not include explicit set-asides for disadvantaged enterprises. Beyond this single misaligned record, the source provides no additional recent opportunities, geographic concentration, or issuing-body pattern for tiagabine procurement across state and local jurisdictions.